A detailed history of Callan Family Office, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 2,288 shares of WST stock, worth $597,991. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,288
Previous 3,469 34.04%
Holding current value
$597,991
Previous $759 Million 20.92%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$210.08 - $279.1 $248,104 - $329,617
-1,181 Reduced 34.04%
2,288 $600 Million
Q2 2025

Jul 24, 2025

BUY
$190.39 - $227.7 $284,823 - $340,639
1,496 Added 75.82%
3,469 $759 Million
Q1 2025

May 12, 2025

BUY
$199.11 - $347.87 $62,520 - $109,231
314 Added 18.93%
1,973 $442 Million
Q4 2024

Feb 06, 2025

BUY
$285.69 - $344.0 $473,959 - $570,696
1,659 New
1,659 $543 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $19.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.